STAT+: Pharmalittle: Global demand for monkeypox vaccine will be hard to meet; Amgen dispute with IRS heats up

Amgen is in a heated fight with the U.S. Internal Revenue Service over its international tax strategy and $10.7 billion in back taxes and penalties the agency says it is…

Click to view original post